# Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders

> **NCT03408886** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Arizona State University** · enrollment: 55 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Gastrointestinal Disorder

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** MoviPrep
- **BIOLOGICAL:** Full Spectrum Microbiota

## Key facts

- **NCT ID:** NCT03408886
- **Lead sponsor:** Arizona State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-04
- **Primary completion:** 2022-04-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03408886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03408886, "Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03408886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*